Vasoactive intestinal polypeptide (VIP) in lung function and disease.
Said
S I
SI
Department of Medicine, University of Illinois, Chicago College of Medicine.
D000818:Animals; D000893:Anti-Inflammatory Agents; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D008168:Lung / Q000378:metabolism* / Q000502:physiology; D009479:Neuropeptides / Q000378:metabolism / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism / Q000502:physiology; D011964:Receptors, Gastrointestinal Hormone / Q000378:metabolism; D018005:Receptors, Vasoactive Intestinal Peptide; D015290:Second Messenger Systems; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology
D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D011964:Receptors, Gastrointestinal Hormone; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide; D000242:Cyclic AMP